The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; MSD; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Pierre Fabre
Skin adverse events of anti-cancer treatments: An examination of drug-AE associations.
 
Samir Salah
Employment - La Roche-Posay/L'Oreal
Leadership - L'Oreal
Stock and Other Ownership Interests - L'Oreal
 
Delphine Kerob
Employment - La Roche-Posay/L'Oreal
Leadership - L'Oreal
Stock and Other Ownership Interests - L'Oreal
Honoraria - L'Oreal
Research Funding - L'Oreal
 
Cécile Pagès
No Relationships to Disclose
 
Mario E. Lacouture
Stock and Other Ownership Interests - Oncoderm (I)
Honoraria - Apricity Health; AstraZeneca; Deciphera; Hoth Therapeutics; Incyte; Innovaderm; Janssen; Kinnate Biopharma; Kintara Therapeutics; Kintara Therapeutics; L'Oreal; La Roche-Posay; Loxo; Lutris; MJH Associates; Nanology; Novartis; Novocure; OnQuality Pharmaceuticals; RBC consultants; Relay Therapeutics; Repare Therapeutics; Roche/Genentech; Seagen; Seattle Genetics/Astellas; Trifecta; Tyra Biosciences
Consulting or Advisory Role - Apricity Health; AstraZeneca; Deciphera; Genentech; Incyte; Innovaderm; Janssen Research & Development; Kinnate Biopharma; Kintara Therapeutics; Kintara Therapeutics; La Roche-Posay; Loxo; Loxo; Lutris; Novartis; Novocure; OnQuality Pharmaceuticals; Relay Therapeutics; Repare Therapeutics; Repare Therapeutics; Roche; Roche; Seagen; Tyra Biosciences
Research Funding - AstraZeneca/MedImmune (Inst); Columbia University (Inst); Lutris (Inst); Lutris (Inst); National Jewish Health (Inst); Novartis (Inst); novocure (Inst); novocure (Inst); OnQuality Pharmaceuticals; OnQuality Pharmaceuticals (Inst); Paxman (Inst)
Other Relationship - Oncoderm (I)
(OPTIONAL) Uncompensated Relationships - Oncoderm
 
Vincent Sibaud
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Incyte; L'Oreal; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Incyte; L'Oreal; MSD; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Novartis; Pierre Fabre